Stalled Initiatives to Cut Drug Prices Frustrate Trump - (The Wall Street Journal via NewsPoints Desk)

  • The Wall Street Journal reported that US President Donald Trump is campaigning for re-election in 2020 by saying he has made progress in reducing drug prices, but the issue has been a source of frustration for him, according to people familiar with the matter.

  • A poll last month by the Kaiser Family Foundation found that 54% of Americans disapprove of Trump’s handling of the costs of prescription drugs.

  • The lack of a major success is needling Trump, who has become frustrated without a signature accomplishment on drug pricing, according to people familiar with the matter, while he has taken to task Health and Human Services Secretary Alex Azar, one of these people said.

  • Trump has publicly characterized his work on lowering drug costs as an achievement while blaming Democrats for blocking more progress.

  • "Last year drug prices fell for the first time in almost 50 years, and he will continue to consider any and all tools to ensure that the decline continues," said deputy White House press secretary Judd Deere.

  • According to an analysis from Rx Savings Solutions, more than 60 drugmakers raised prices in the US at the start of 2020, but the acceleration in prices had slowed year-to-year. 

To read more NewsPoints articles, click here.

Reference Articles